Alnylam Pharmaceuticals, Inc.
Price · 20 sessions
$294.32-5.39%Signal status
Score breakdown · 20D
01:36 PM · 5 minutes agoUpdated 01:36 PM (New York, ET) · 5 minutes ago
Source: yahoo-financeCurrent market state
stock
Signal History
No history yet. Appears after admin saves daily snapshots.
News
New Analyst Forecast: $ALNY Given $470 Price Target
New Analyst Forecast: $ALNY Given $470 Price Target Quiver Quantitative
Analyst reveals the simple rule that could help you survive any crypto downturn
Analyst reveals the simple rule that could help you survive any crypto downturn thestreet.com
Alnylam expands use of Komodo’s AI platform across its enterprise
Alnylam expands use of Komodo’s AI platform across its enterprise Stock Titan
SpaceX is vastly more expensive than any stock in the S&P 500, fueled by ‘FOMO’ mentality
SpaceX is vastly more expensive than any stock in the S&P 500, fueled by ‘FOMO’ mentality MarketWatch
Webcasts tackle RNAi programs for bleeding, blood pressure and Huntington's
Webcasts tackle RNAi programs for bleeding, blood pressure and Huntington's Stock Titan
Alnylam Stock Is Running Its Own Race. Here's What That Means for Your Portfolio.
Alnylam Stock Is Running Its Own Race. Here's What That Means for Your Portfolio. Trefis
Alnylam slides as investors refocus on near-term Amvuttra growth after recent AI-deal headlines | ALNY Stock News
Alnylam slides as investors refocus on near-term Amvuttra growth after recent AI-deal headlines | ALNY Stock News Quiver Quantitative
ALNY - Alnylam Pharmaceuticals Inc Stock Price and Quote
ALNY - Alnylam Pharmaceuticals Inc Stock Price and Quote Finviz
A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Choppy Trading And Rich P/E Multiple
A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Choppy Trading And Rich P/E Multiple Yahoo Finance
How Alnylam Stock Weathers Market Shocks
How Alnylam Stock Weathers Market Shocks Forbes
Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock
Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock Yahoo Finance
Down 34% From All-Time Highs, Can Alnylam Pharmaceuticals Stock Finally Recover In 2026?
Down 34% From All-Time Highs, Can Alnylam Pharmaceuticals Stock Finally Recover In 2026? TIKR.com